{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:49Z","timestamp":1793237689232,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000},"content-version":"vor","delay-in-days":117,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-038139"],"award-info":[{"award-number":["INV-038139"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-017692"],"award-info":[{"award-number":["INV-017692"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI174304"],"award-info":[{"award-number":["R01AI174304"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL141781"],"award-info":[{"award-number":["R01HL141781"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08AI183990"],"award-info":[{"award-number":["K08AI183990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL128288"],"award-info":[{"award-number":["R01HL128288"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2025ZD01904400"],"award-info":[{"award-number":["2025ZD01904400"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ymthe.2026.03.018","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:38:24Z","timestamp":1773419904000},"page":"4084-4103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro and in vivo base editing of CCR5 in hematopoietic stem cells confers HIV-1 resistance"],"prefix":"10.1016","volume":"34","author":[{"given":"Anna K.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aphrodite","family":"Georgakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Riker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik V.","family":"Karuppusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-5168","authenticated-orcid":false,"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.03.018_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109741","article-title":"Antiretrovirals to CCR5 CRISPR\/Cas9 gene editing - A paradigm shift chasing an HIV cure","volume":"255","author":"Khan","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41591-019-0710-1","article-title":"No statistical evidence for an effect of CCR5-\u039432 on lifespan in the UK Biobank cohort","volume":"26","author":"Maier","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1468-1293.2007.00455.x","article-title":"Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion","volume":"8","author":"Laurichesse","year":"2007","journal-title":"HIV Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.03.018_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","article-title":"In-depth virological and immunological characterization of HIV-1 cure after CCR5Delta32\/Delta32 allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","article-title":"HIV-1 remission and possible cure in a woman after haplo-cord blood transplant","volume":"186","author":"Hsu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.03.018_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40169-020-0268-z","article-title":"The clinical potential of gene editing as a tool to engineer cell-based therapeutics","volume":"9","author":"Ashmore-Harris","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.67","article-title":"Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem\/progenitor cells","volume":"3","author":"DiGiusto","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.omtm.2023.07.006","article-title":"Efficient manufacturing and engraftment of CCR5 gene-edited HSPCs following busulfan conditioning in nonhuman primates","volume":"30","author":"Murray","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib12","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2016-04-711580","article-title":"In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors","volume":"128","author":"Richter","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.03.018_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139538","article-title":"Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2026.03.018_bib14","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ymthe.2020.09.001","article-title":"In Vivo HSC Gene Therapy Using a Bi-modular HDAd5\/35++ Vector Cures Sickle Cell Disease in a Mouse Model","volume":"29","author":"Li","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.018_bib15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/bloodadvances.2020003702","article-title":"In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal gamma-globin in beta-YAC mice","volume":"5","author":"Li","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2026.03.018_bib16","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2018-03-838540","article-title":"Reactivation of gamma-globin in adult beta-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing","volume":"131","author":"Li","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.03.018_bib17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI122836","article-title":"In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.03.018_bib18","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.ymthe.2019.08.006","article-title":"Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5\/35++ Vectors","volume":"27","author":"Li","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.018_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.omtm.2018.02.004","article-title":"Integrating HDAd5\/35++ vectors as a new platform of HSC gene therapy of hemoglobinopathies","volume":"9","author":"Li","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR\u2013Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib22","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib23","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.ymthe.2021.09.002","article-title":"In vivo somatic cell base editing and prime editing","volume":"29","author":"Newby","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.018_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nmeth.4327","article-title":"CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations","volume":"14","author":"Kuscu","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.03.018_bib25","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.molcel.2017.08.008","article-title":"CRISPR-Mediated Base Editing Enables Efficient Disruption of Eukaryotic Genes through Induction of STOP Codons","volume":"67","author":"Billon","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2026.03.018_bib26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ymthe.2019.11.022","article-title":"Efficient Gene Silencing by Adenine Base Editor-Mediated Start Codon Mutation","volume":"28","author":"Wang","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.018_bib27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymthe.2021.10.026","article-title":"Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing","volume":"30","author":"Knipping","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.018_bib28","doi-asserted-by":"crossref","unstructured":"Li, C., Georgakopoulou, A., Gil, S., and Lieber, A. Highly efficient and safe in vivo HSC base editing for the treatment of hemoglobinopathies. Abstract # 1218. 2022 ASGCT Annual Meeting Abstracts. Molecular Therapy 30, 1-592. https:\/\/doi.org\/10.1016\/j.ymthe.2022.04.017.","DOI":"10.1016\/j.ymthe.2022.04.017"},{"key":"10.1016\/j.ymthe.2026.03.018_bib29","doi-asserted-by":"crossref","unstructured":"Li, C., Newby, G.A., Gil, S., Kiem, H.-P., Liu, D.R., and Lieber, A. Correction of the Sickle Cell Mutation by In Vivo HSC Prime Editing in a Mouse Model. Abstract # 809. 2022 ASGCT Annual Meeting Abstracts. Molecular Therapy 30, 1-592. https:\/\/doi.org\/10.1016\/j.ymthe.2022.04.017.","DOI":"10.1016\/j.ymthe.2022.04.017"},{"key":"10.1016\/j.ymthe.2026.03.018_bib30","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2026.03.018_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41587-022-01533-6","article-title":"Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity","volume":"41","author":"Neugebauer","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib32","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1038\/s41467-024-49473-w","article-title":"High performance TadA-8e derived cytosine and dual base editors with undetectable off-target effects in plants","volume":"15","author":"Fan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.018_bib33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib34","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1099\/vir.0.000139","article-title":"Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9","volume":"96","author":"Li","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib35","article-title":"Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5\/35 vectors expressing site-specific endonucleases under microRNA regulation","volume":"1","author":"Saydaminova","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib36","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.omtm.2020.01.014","article-title":"A Single \u201cAll-in-One\u201d Helper-Dependent Adenovirus to Deliver Donor DNA and CRISPR\/Cas9 for Efficient Homology-Directed Repair","volume":"17","author":"Palmer","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib37","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.ymthe.2024.10.018","article-title":"Introducing a hemoglobin G-Makassar variant in HSCs by in vivo base editing treats sickle cell disease in mice","volume":"32","author":"Li","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.018_bib38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.omtm.2023.03.008","article-title":"HDAd6\/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells","volume":"29","author":"Wang","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib39","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.2020010020","article-title":"Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo","volume":"138","author":"Psatha","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.03.018_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ymthe.2018.09.017","article-title":"Long-Term Persistence of Anti-HIV Broadly Neutralizing Antibody-Secreting Hematopoietic Cells in Humanized Mice","volume":"27","author":"Kuhlmann","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.018_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/hgtb.2014.005","article-title":"Superior long-term repopulating capacity of G-CSF+plerixafor-mobilized blood: implications for stem cell gene therapy by studies in the Hbb(th-3) mouse model","volume":"25","author":"Psatha","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.ymthe.2026.03.018_bib42","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib43","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","article-title":"Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases","volume":"30","author":"Bae","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2026.03.018_bib44","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41587-020-0555-7","article-title":"CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity","volume":"38","author":"Lazzarotto","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nmeth.4278","article-title":"CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets","volume":"14","author":"Tsai","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2026.03.018_bib46","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","article-title":"Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors","volume":"38","author":"Doman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib47","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s41588-023-01434-7","article-title":"Potent and uniform fetal hemoglobin induction via base editing","volume":"55","author":"Mayuranathan","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.03.018_bib48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4+ T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib49","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-025-55873-3","article-title":"High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection","volume":"16","author":"Claiborne","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.018_bib50","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162939","article-title":"In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies","volume":"7","author":"Li","year":"2022","journal-title":"JCI insight"},{"key":"10.1016\/j.ymthe.2026.03.018_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.omtm.2021.12.003","article-title":"Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5\/35++ vectors","volume":"24","author":"Li","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib53","first-page":"2085","article-title":"In vivo HSC prime editing rescues sickle cell disease in a mouse model","volume":"141","author":"Li","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.03.018_bib54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13059-018-1482-5","article-title":"CRISPR-SKIP: programmable gene splicing with single base editors","volume":"19","author":"Gapinske","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib55","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.omtn.2020.07.037","article-title":"CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations","volume":"21","author":"Chen","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.03.018_bib56","doi-asserted-by":"crossref","first-page":"30662","DOI":"10.1074\/jbc.272.49.30662","article-title":"The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons","volume":"272","author":"Mummidi","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.03.018_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1570162X16666180817115830","article-title":"Host Restriction Factors and Human Immunodeficiency Virus (HIV-1): A Dynamic Interplay Involving All Phases of the Viral Life Cycle","volume":"16","author":"V","year":"2018","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ymthe.2026.03.018_bib58","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57646","article-title":"Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation","volume":"10","author":"Cardozo-Ojeda","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2026.03.018_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101448","article-title":"In vivo HSC transduction in humanized mice mediated by novel capsid-modified HDAd vectors","volume":"33","author":"Georgakopoulou","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib60","doi-asserted-by":"crossref","unstructured":"Wang, H., Huang, L., Mishra, A., Gil, S., Hawkins, D., and Lieber, A. Improving the Safety and Efficacy of In Vivo Genome Editing in HSCs by Using Strong HSC-Specific Promoters and a Pomalidomide-Induction-System to Regulate the Level and Duration of Editor Expression after HDAd Gene Transfer. Abstract # 606. ASGCT 28th Annual Meeting Abstracts. (2025). Molecular Therapy 33, 1-1667. https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.028.","DOI":"10.1016\/j.ymthe.2025.04.028"},{"key":"10.1016\/j.ymthe.2026.03.018_bib61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13578-020-00444-w","article-title":"Genome editing of CCR5 by AsCpf1 renders CD4(+)T cells resistance to HIV-1 infection","volume":"10","author":"Liu","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ymthe.2026.03.018_bib62","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101319","article-title":"Auto-expansion of in vivo HDAd-transduced hematopoietic stem cells by constitutive expression of tHMGA2","volume":"32","author":"Wang","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.03.018_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115141","article-title":"Dual alpha-globin-truncated erythropoietin receptor knockin restores hemoglobin production in alpha-thalassemia-derived erythroid cells","volume":"44","author":"Chu","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.03.018_bib65","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1038\/s41467-025-58371-8","article-title":"Multilayered HIV-1 resistance in HSPCs through CCR5 Knockout and B cell secretion of HIV-inhibiting antibodies","volume":"16","author":"Feist","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.03.018_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5409","article-title":"AAV-delivered eCD4-Ig protects rhesus macaques from high-dose SIVmac239 challenges","volume":"11","author":"Gardner","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.03.018_bib67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ymthe.2026.03.018_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41541-023-00674-2","article-title":"Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration","volume":"8","author":"Zhang","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.03.018_bib69","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ymthe.2023.02.002","article-title":"Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIV","volume":"31","author":"Li","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.03.018_bib70","doi-asserted-by":"crossref","first-page":"10567","DOI":"10.1128\/JVI.01308-08","article-title":"In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46","volume":"82","author":"Wang","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1365-2249.2001.01458.x","article-title":"Membrane cofactor protein (MCP; CD46) expression in transgenic mice","volume":"124","author":"Kemper","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/crispr.2018.0014","article-title":"EditR: A Method to Quantify Base Editing from Sanger Sequencing","volume":"1","author":"Kluesner","year":"2018","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.03.018_bib73","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.03.018_bib74","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","article-title":"Cas-analyzer: an online tool for assessing genome editing results using NGS data","volume":"33","author":"Park","year":"2017","journal-title":"Bioinformatics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626002030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:27:02Z","timestamp":1793237222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626002030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1525001626002030"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.018","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo base editing of CCR5 in hematopoietic stem cells confers HIV-1 resistance","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}